Skip to main content

Table 5 Knowledge of paediatric (<2 years of age) quality-assured ACT dosing regimen among respondents from private for-profit outlets with quality-assured ACT in stock on the day of the survey at baseline (2010) and endline (2011)

From: Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention

Country Baseline (%) Endline (%) Percentage point change (95% confidence interval)
Ghana 31.4 47.8 16.4 (8.7-24.0)
Kenya 67.4 60.6 −6.8 (−17.0-3.5)
Tanzania mainland 60.0 89.5 29.5 (11.7-47.1)
Zanzibar 15.4 48.7 33.3
Nigeria* - 53.7 -
Niger 64.1 43.1 −21.0 (−34.3-7.8)
Madagascar* - 41.6 -
Uganda 64.1 78.5 14.4 (3.3-25.4)
  1. Correct knowledge of paediatric quality-assured ACT dosing regimen was measured as respondents that correctly stated the number of tablets that should be taken at a time, the number of times the medicine should be taken per day, and the duration of the dose in number of days for child under 2 years (10 kg) for a specific product which they selected from the quality-assured ACT that they stocked.
  2. Nigeria baseline data collection was conducted in 2009. No confidence interval is shown for Zanzibar as a full census was carried out. Settings are roughly ordered by intensity of communication campaign and training intervention implementation (see Table 3).
  3. *These data are not available for Madagascar and Nigeria at baseline, as they were not collected in the ACTwatch survey.